136 related articles for article (PubMed ID: 11338850)
1. [Postinfarction remodeling of the left atrium and left ventricle: effects of long-term treatment with beta adrenergic blockers and angiotensin converting enzyme inhibitors].
Mazur NA; Vikent'ev VV
Ter Arkh; 2001; 73(2):29-32. PubMed ID: 11338850
[TBL] [Abstract][Full Text] [Related]
2. [MRT assessment of metabolic and thrombolytic therapy effects on postinfarction left ventricular remodeling].
Tarasov NI; Kokov AN; Barbarash LS
Ter Arkh; 2006; 78(9):38-43. PubMed ID: 17076223
[TBL] [Abstract][Full Text] [Related]
3. Effect of early treatment with captopril and metoprolol singly and together on postinfarction left ventricular remodeling.
Ricci R; Coletta C; Ceci V; Pajes G; Putini RL; Salustri A; Bottero G; Pasquale M;
Am Heart J; 2001 Oct; 142(4):E5. PubMed ID: 11579369
[TBL] [Abstract][Full Text] [Related]
4. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L
Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
6. Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor.
Hamada M; Hara Y; Ohtsuka T; Suzuki J; Saeki H; Ogimoto A; Shigematsu Y
J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S5-10. PubMed ID: 12688389
[TBL] [Abstract][Full Text] [Related]
7. Effects of zofenopril on myocardial ischemia in post-myocardial infarction patients with preserved left ventricular function: the Survival of Myocardial Infarction Long-term Evaluation (SMILE)-ISCHEMIA study.
Borghi C; Ambrosioni E;
Am Heart J; 2007 Mar; 153(3):445.e7-14. PubMed ID: 17307427
[TBL] [Abstract][Full Text] [Related]
8. Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study.
Ferrari R;
Arch Intern Med; 2006 Mar; 166(6):659-66. PubMed ID: 16567606
[TBL] [Abstract][Full Text] [Related]
9. The effects of replacing beta-blockers with an angiotensin converting enzyme inhibitor on the quality of life of hypertensive patients.
Paran E; Anson O; Neumann L
Am J Hypertens; 1996 Dec; 9(12 Pt 1):1206-13. PubMed ID: 8972892
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
Califf RM; Lokhnygina Y; Velazquez EJ; McMurray JJ; Leimberger JD; Lewis EF; Diaz R; Murin J; Pfeffer MA
Am J Cardiol; 2009 Jul; 104(2):151-7. PubMed ID: 19576338
[TBL] [Abstract][Full Text] [Related]
11. Relation between left ventricular remodeling and clinical outcomes in heart failure patients with left ventricular systolic dysfunction.
Udelson JE; Konstam MA
J Card Fail; 2002 Dec; 8(6 Suppl):S465-71. PubMed ID: 12555159
[TBL] [Abstract][Full Text] [Related]
12. Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction.
Solomon SD; Skali H; Anavekar NS; Bourgoun M; Barvik S; Ghali JK; Warnica JW; Khrakovskaya M; Arnold JM; Schwartz Y; Velazquez EJ; Califf RM; McMurray JV; Pfeffer MA
Circulation; 2005 Jun; 111(25):3411-9. PubMed ID: 15967846
[TBL] [Abstract][Full Text] [Related]
13. Ventricular remodeling and its prevention in the treatment of heart failure.
Patten RD; Udelson JE; Konstam MA
Curr Opin Cardiol; 1998 May; 13(3):162-7. PubMed ID: 9649938
[TBL] [Abstract][Full Text] [Related]
14. Left ventricular remodeling: pathophysiology and treatment.
Sharpe N
Heart Fail Monit; 2003; 4(2):55-61. PubMed ID: 14724719
[TBL] [Abstract][Full Text] [Related]
15. Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function.
Orn S; Manhenke C; Squire IB; Ng L; Anand I; Dickstein K
J Card Fail; 2007 Dec; 13(10):843-9. PubMed ID: 18068618
[TBL] [Abstract][Full Text] [Related]
16. Effects of canrenoate plus angiotensin-converting enzyme inhibitors versus angiotensin-converting enzyme inhibitors alone on systolic and diastolic function in patients with acute anterior myocardial infarction.
Di Pasquale P; Cannizzaro S; Scalzo S; Parrinello G; Fasullo S; Giambanco F; Fatta A; Paterna S
Am Heart J; 2005 Nov; 150(5):919. PubMed ID: 16290961
[TBL] [Abstract][Full Text] [Related]
17. Effects of angiotensin converting enzyme inhibitors on remodeling in clinical trials.
Greenberg BH
J Card Fail; 2002 Dec; 8(6 Suppl):S486-90. PubMed ID: 12555162
[TBL] [Abstract][Full Text] [Related]
18. Effects of ACE-inhibitors and beta-blockers on left ventricular remodeling in chronic heart failure.
Khattar RS
Minerva Cardioangiol; 2003 Apr; 51(2):143-54. PubMed ID: 12783070
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin converting enzyme inhibitor prevents left ventricular remodelling after myocardial infarction in angiotensin II type 1 receptor knockout mice.
Yoshiyama M; Nakamura Y; Omura T; Izumi Y; Matsumoto R; Oda S; Takeuchi K; Kim S; Iwao H; Yoshikawa J
Heart; 2005 Aug; 91(8):1080-5. PubMed ID: 16020603
[TBL] [Abstract][Full Text] [Related]
20. Secondary prevention of cardiac events following myocardial infarction: effects of atenolol and enalapril. Beijing Collaborative Study Group.
Wu N; Fan Z
Chin Med J (Engl); 1997 Aug; 110(8):602-6. PubMed ID: 9594263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]